The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes
about
An update on the use of NOD mice to study autoimmune (Type 1) diabetes.The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injuryResetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors.Inhibition of adenovirus multiplication by inosine pranobex and interferon α in vitro.
P2860
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The novel inosine analogue, IN ...... ouse models of type I diabetes
@en
The novel inosine analogue, IN ...... use models of type I diabetes.
@nl
type
label
The novel inosine analogue, IN ...... ouse models of type I diabetes
@en
The novel inosine analogue, IN ...... use models of type I diabetes.
@nl
prefLabel
The novel inosine analogue, IN ...... ouse models of type I diabetes
@en
The novel inosine analogue, IN ...... use models of type I diabetes.
@nl
P2093
P2860
P356
P1476
The novel inosine analogue, IN ...... ouse models of type I diabetes
@en
P2093
Andrew L Salzman
Csaba Szabo
Garry J Southan
Jon G Mabley
Kanneganti G K Murthy
William Williams
P2860
P304
P356
10.1677/JOE-07-0511
P407
P50
P577
2008-06-18T00:00:00Z